Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease

Document Type

Article

Publication Date

2017

Publication Title

The Journal of Pharmacology and Experimental Therapeutics

DOI

10.1124/jpet.117.241653

Comments

Please see the work itself for the complete list of authors.

Publisher's Statement

The original material can be found here: https://doi.org/10.1124/jpet.117.241653

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 78
  • Usage
    • Abstract Views: 16
  • Captures
    • Readers: 95
  • Mentions
    • News Mentions: 1
see details

Share

COinS